Learning from Davos
The annual meeting of the World Economic Forum at Davos at the end of January attracted the usual headlines as world leaders laid down their agendas for the coming year and beyond.
Healthcare Showing 8 of 8 results in category "Healthcare"
Sparking innovation
GlaxoSmithKline (GSK) faced a situation common to large global organisations: how to allocate marketing resources to smaller, regional brands.
Combine harvesting
Julian Birkinshaw and Stuart Crainer report on how Roche Diagnostics is exploring an experimental approach to harvesting bright ideas.
Curing healthcare
No one running a company, large or small, can ignore the rising costs of healthcare. Yet, for all the attention paid to it, few companies feel that they have a state-of-the-art healthcare system.
From R&D to Connect = Develop at P&G
Challenged by its CEO to source ideas from outside, Procter & Gamble decided to blaze a new path for its research and development function. In pursuit of inspiration, its R&D became turbocharged by using “insourcing” to expand P&G’s horizons.
Beyond Botox: David Pyott
David Pyott is chairman and CEO of the global healthcare company Allergan. Headquartered in Irvine, California, Allergan provides speciality pharmaceutical products worldwide, developing and commercialising products in ophthalmology.
Sources of advantage
Technology and bio-medical companies create success cycles by the way they perform four critical business processes. Peter S. Cohan and Barry Unger reveal the implications.
Succeeding with values
Randall L Tobias is the former president, chairman and CEO of the pharmaceutical giant Eli Lilly. Under his leadership in the 1990s Eli Lilly experienced a dramatic turnaround and enjoyed one of the most successful periods in its history.
"London Business School empowers individuals and organisations to perform at their best."
